|
ヤマト マサユキ
YAMATO Masayuki
大和 雅之 所属 医学研究科 医学研究科 (医学部医学科をご参照ください) 職種 教授 |
|
| 論文種別 | 原著 |
| 言語種別 | 英語 |
| 査読の有無 | 査読あり |
| 表題 | Validation of the efficacy of tympanoplasty combined with cell sheet transplantation. |
| 掲載誌名 | 正式名：Auris, nasus, larynx 略 称：Auris Nasus Larynx ISSNコード：18791476/03858146 |
| 掲載区分 | 国外 |
| 巻・号・頁 | 53(4),pp.493-499 |
| 著者・共著者 | YAMAMOTOKazuhisa*, MORINO Tsunetaro, BABA Akira, KASAI Yoshiyuki, KIKUCHI Shun, TAKIZAWA Yuki, MOTEGI Masaomi, KOMORI Manabui, YAMAMOTO Yutak, YAMATO Masayuki, KOJIMA Hiromi |
| 発行年月 | 2026/05 |
| 概要 | OBJECTIVE:To evaluate postoperative mastoid aeration following canal wall up tympanoplasty with mastoidectomy combined with autologous nasal epithelial cell sheet transplantation into the middle ear cavity and to compare the outcomes with those of conventional canal wall up tympanoplasty with mastoidectomy.METHODS:Five patients with acquired cholesteatoma (four pars flaccida types and one pars tensa type) underwent canal wall up tympanoplasty with mastoidectomy combined with autologous cultured nasal epithelial cell sheet transplantation into the middle ear cavity (cell sheet group). Sixty-two patients who underwent conventional canal wall up tympanoplasty without cell sheet transplantation served as the controls. Mastoid cavity aeration was evaluated one year postoperatively using temporal bone CT scans.RESULTS:All five patients (100%) in the cell sheet group achieved mastoid cavity aeration within 1 year after surgery, and aeration was maintained during the follow-up period. Conversely, only 38.7% (24/62) of patients in the control group demonstrated postoperative mastoid aeration on CT. No adverse events or complications related to the cell sheet transplantation were noted.CONCLUSION:The combination of canal wall up tympanoplasty with autologous nasal mucosal epithelial cell sheet transplantation achieved adequate aeration of the mastoid cavity 1 year postoperatively. This regenerative approach may improve postoperative middle ear aeration and potentially contribute to the long-term prevention of recurrent cholesteatoma while preserving the physiological structure of the external auditory canal. |
| DOI | 10.1016/j.anl.2026.04.010 |
| PMID | 42150323 |